Hansoh Pharmaceutical Group Company Limited (HKG:3692)
34.36
-0.98 (-2.77%)
Sep 1, 2026, 4:08 PM HKT
HKG:3692 Market Cap
HKG:3692 has a market cap or net worth of 208.32 billion as of September 1, 2026. Its market cap has decreased by -4.46% in one year.
Market Cap
208.32B
Enterprise Value
170.05B
Revenue
18.35B
Ranking
n/a
PE Ratio
26.87
Stock Price
34.36
ChartMarket Cap Chart
Since June 14, 2019, HKG:3692's market cap has increased from 111.27B to 208.32B, an increase of 87.23%. That is a compound annual growth rate of 9.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 208.32B | -4.63% |
| Dec 31, 2025 | 218.43B | 113.01% |
| Dec 31, 2024 | 102.55B | 9.84% |
| Dec 29, 2023 | 93.36B | 6.25% |
| Dec 30, 2022 | 87.86B | -21.92% |
| Dec 31, 2021 | 112.52B | -49.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Simcere Pharmaceutical Group | 28.51B |
| China Resources Pharmaceutical Group | 28.08B |
| China Medical System Holdings | 27.25B |
| Sunshine Lake Pharma | 21.96B |
| Grand Pharmaceutical Group | 17.58B |
| The United Laboratories International Holdings | 16.27B |
| Fujian Haixi Pharmaceuticals | 15.11B |
| CanSino Biologics | 13.97B |